[go: up one dir, main page]

FR3101544B1 - Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères - Google Patents

Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères Download PDF

Info

Publication number
FR3101544B1
FR3101544B1 FR1911097A FR1911097A FR3101544B1 FR 3101544 B1 FR3101544 B1 FR 3101544B1 FR 1911097 A FR1911097 A FR 1911097A FR 1911097 A FR1911097 A FR 1911097A FR 3101544 B1 FR3101544 B1 FR 3101544B1
Authority
FR
France
Prior art keywords
xaa
peptide
chosen
skin
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1911097A
Other languages
English (en)
Other versions
FR3101544A1 (fr
Inventor
Philippe Mondon
Caroline Ringenbach
Thibault Marchand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=69810924&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR3101544(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sederma SA filed Critical Sederma SA
Priority to FR1911097A priority Critical patent/FR3101544B1/fr
Priority to PCT/EP2020/077974 priority patent/WO2021069426A2/fr
Priority to KR1020227014454A priority patent/KR20220079586A/ko
Priority to EP20785979.4A priority patent/EP4041184A2/fr
Priority to US17/765,707 priority patent/US20220347075A1/en
Priority to CN202080070461.XA priority patent/CN114555045A/zh
Priority to JP2022521060A priority patent/JP2022550991A/ja
Publication of FR3101544A1 publication Critical patent/FR3101544A1/fr
Publication of FR3101544B1 publication Critical patent/FR3101544B1/fr
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

TRAITEMENT COSMÉTIQUE OU DERMATOLOGIQUE A BASE DE PEPTIDE(S) DE LA PEAU ET DE SES PHANÈRES Le traitement selon l’invention prévoit l’utilisation d’au moins un peptide de formule générale X-(Xaa)nK*TTK*X’aa-(Xaa)m-Z pour un traitement cosmétique non-thérapeutique des matières kératiniques de la peau et de ses phanères. Dans la formule, K* est choisi parmi la lysine, l’hydroxylysine, l’ornithine, l’acide diaminobutyrique ou l’acide diaminopropionique ou leurs dérivés formylé, acétylé, trifluoroacetylé, méthanesulfonylé ou succinylé, les deux K* pouvant être identiques ou différents ; (Xaa)n et (Xaa)m correspondent indépendammment l’une de l’autre à une séquence de n ou m acides aminés Xaa choisis indépendamment les uns des autres parmi Gly, Ala, Pro, Val, Leu, Ile et Phe, avec n et m des nombres entiers qui peuvent être égaux ou différents compris entre 0 et 5 ; X’aa correspond à S ou T, en extrémité N-terminale X choisi parmi H, -CO-R1, -SO2-R1 ou un groupe biotinoyle ; en extrémité C-terminale Z choisi parmi OH, OR1, NH2, NHR1 ou NR1R2 ; et R1 et R2 étant, indépendamment l’un de l’autre, choisis parmi un groupement alkyle, aryle, aralkyle, alkylaryl, alkoxy, saccharide et aryloxy, pouvant être linéaire, ramifié, cyclique, polycyclique, insaturé, hydroxylé, carbonylé, phosphorylé et/ou soufré, ledit groupement ayant de 1 à 24 atomes de carbone et pouvant posséder dans son squelette un hétéroatome O, S et/ou N. Un peptide préféré est le Pal-KTTKS.
FR1911097A 2019-10-07 2019-10-07 Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères Active FR3101544B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1911097A FR3101544B1 (fr) 2019-10-07 2019-10-07 Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères
US17/765,707 US20220347075A1 (en) 2019-10-07 2020-10-06 Peptide based cosmetic or dermatological treatment of the skin and its appendages
KR1020227014454A KR20220079586A (ko) 2019-10-07 2020-10-06 피부 및 피부 부속물의 펩티드 기반 화장 또는 피부과학적 처치
EP20785979.4A EP4041184A2 (fr) 2019-10-07 2020-10-06 Traitement cosmétique ou dermatologique de la peau et de phanères à base de peptides
PCT/EP2020/077974 WO2021069426A2 (fr) 2019-10-07 2020-10-06 Traitement cosmétique ou dermatologique de la peau et de phanères à base de peptides
CN202080070461.XA CN114555045A (zh) 2019-10-07 2020-10-06 皮肤及其附属物的基于肽的美容或皮肤病学处理
JP2022521060A JP2022550991A (ja) 2019-10-07 2020-10-06 皮膚及びその付属器の、ペプチドに基づいた化粧品又は皮膚科学的な処置

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1911097A FR3101544B1 (fr) 2019-10-07 2019-10-07 Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères
FR1911097 2019-10-07

Publications (2)

Publication Number Publication Date
FR3101544A1 FR3101544A1 (fr) 2021-04-09
FR3101544B1 true FR3101544B1 (fr) 2023-09-29

Family

ID=69810924

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1911097A Active FR3101544B1 (fr) 2019-10-07 2019-10-07 Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères

Country Status (7)

Country Link
US (1) US20220347075A1 (fr)
EP (1) EP4041184A2 (fr)
JP (1) JP2022550991A (fr)
KR (1) KR20220079586A (fr)
CN (1) CN114555045A (fr)
FR (1) FR3101544B1 (fr)
WO (1) WO2021069426A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024106586A1 (fr) * 2022-11-18 2024-05-23 (주)케어젠 Peptide ayant des activités de promotion de la pousse des cheveux et d'inhibition de la chute des cheveux et son utilisation
CN118236385B (zh) * 2024-05-28 2024-08-09 长春中医药大学 一种具有抗衰老和美白功效的组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2998570B1 (fr) 2012-11-26 2016-12-02 Sederma Sa Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
FR3021319B1 (fr) * 2014-05-22 2018-08-31 Sederma Peptides, compositions les comprenant et utilisations notamment cosmetiques
CN106794130B (zh) * 2014-09-17 2020-11-27 宝洁公司 护肤产品和使用方法
FR3029782B1 (fr) 2014-12-16 2019-06-07 Sederma Composes peptidiques, compositions les comprenant et utilisations notamment cosmetiques
FR3052453B1 (fr) 2016-06-14 2018-05-18 Sederma Peptide, composition le comprenant et utilisations notamment cosmetiques
US20190105261A1 (en) * 2017-10-11 2019-04-11 Illustris Pharmaceuticals, Inc. Methods and compositions for topical delivery
ES2726000A1 (es) * 2018-03-28 2019-10-01 Infinitec Activos S L Nanopartículas de oro y palmitoíl pentapéptido-4

Also Published As

Publication number Publication date
FR3101544A1 (fr) 2021-04-09
JP2022550991A (ja) 2022-12-06
WO2021069426A3 (fr) 2021-06-03
US20220347075A1 (en) 2022-11-03
EP4041184A2 (fr) 2022-08-17
CN114555045A (zh) 2022-05-27
KR20220079586A (ko) 2022-06-13
WO2021069426A2 (fr) 2021-04-15

Similar Documents

Publication Publication Date Title
FR3101544B1 (fr) Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères
CN106999401B (zh) 肽化合物、包含它们的组合物和所述化合物，特别是化妆品的用途
JP5697869B2 (ja) 高分子バイオサーファクタント
EP3087971B1 (fr) Matériau de base contenant un composé de peptide lipidique
FR2788777A1 (fr) Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
FR2441384A1 (fr) Produits cosmetiques du type emulsion huile-dans-l'eau, a base de polypeptides
EP3315138A1 (fr) Matériau de base en bâtonnet comprenant un composé peptide lipidique
CN118530299B (zh) 一种三肽、三肽盐或衍生物及其应用
FR3112941B1 (fr) Traitement cosmétique ou dermatologique à base de peptide(s) de la peau et de ses phanères
EP1363583A2 (fr) Produits cosmetiques et/ou pharmaceutiques contenant des acides amines acyles et des condensats de proteines
KR880012640A (ko) 포스포리파제 a₂- 억제 작용을 갖는 펩티드
Wolfgram et al. THE COMPOSITION OF THE MYELIN PROTEINS OF THE PERIPHERAL NERVOUS SYSTEM 1 2
JP5159311B2 (ja) オリゴペプチドおよびそれらの使用
FR3116273B1 (fr) Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
FR2724937B1 (fr) Polymeres fonctionnalises, leur procede de synthese, leur utilisation comme agents tensioactifs en particulier dans des compositions cosmetiques et notamment des vernis a ongles
US10639263B2 (en) Method for adjusting hardness of stick-shaped base material comprising lipid peptide compound
US20230062111A1 (en) Anti-pollution material
US20200345618A1 (en) Composition containing powder
EP3311797A1 (fr) Matériau de base en bâtonnet contenant un composé peptide lipidique
EP3560480A1 (fr) Base de préparation solide de type bâton pour application externe sur la peau
FR3116274B1 (fr) Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
FR3116275B1 (fr) Tétrapeptide, composition le comprenant et son utilisation cosmétique
DE102018105686A1 (de) Kosmetische oder pharmazeutische Zubereitung zur Pflege der Haut und Verbesserung des Hautzustandes
WO1998053795B1 (fr) Compositions cosmetiques et dermopharmaceutiques contenant des derives de threonine ou de serine
KR970706835A (ko) 위장 손상의 심각도의 감소 방법(Method for Reducing The Severity of Gastro-Intestinal Damage)

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210409

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

OR Opposition filed

Effective date: 20240701

PLFP Fee payment

Year of fee payment: 6